Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin

Pediatric Research

Volumn 47, Issue 1, 2000, Pages 24-35

  Cymerman, Urszula ^a   Vera, Sonia ^a   Pece Barbara, Nadia ^a,b   Bourdeau, Annie ^a,b   White Jr , Robert I ^c   Dunn, James ^d   Letarte, Michelle ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Visible Genetics Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN;

ARTICLE; DISEASE ASSOCIATION; DNA SEQUENCE; ENDOTHELIUM CELL; EXON; FAMILY STUDY; GENE MUTATION; HUMAN; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENDU OSLER WEBER DISEASE; UMBILICAL VEIN;

EID: 0033977915     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200001000-00008     Document Type: Article

References (46)

1. Guttmacher AE, Marchuk DA, White RIJ 1995 Hereditary hemorrhagic telangiectasia. N Engl J Med 333:918-924
2. Hoffman HJ, Mohr G, Kusunoki T 1976 Multiple arteriovenous malformations of spinal cord and brain in a child. Childs Brain 2:317-324
3. Roy C, Noseda G, Arzimanoglou A, Harpey JP, Binet MH, Vaur C, Caille B 1990 Maladie de Rendu-Osler révélée par la rupture d'un anévrisme artériel cérébral chez un nourrisson. Arch Fr Pediatr 47:741-742
4. Belzic I, Yaseen H, Voirin J, Bonte JB, Laloum D 1992 Malformations artério-veineuses cérébrales dans une probable forme familiale de Rendu-Osler. Ann Pediatr 39:301-304
5. John PR 1992 Early childhood presentation of neurovascular disease in hereditary haemorrhagic telangiectasia. Pediatr Radiol 22:140-141
6. Kadoya C, Momota Y, Ikegami Y, Urasaki E, Wada SI, Yokota A 1993 Central nervous system malformations with hereditary hemorrhagic telangiectasia: report of a family with three cases. Surg Neurol 42:234-239
7. Kikuchi K, Kowada M, Sasajima H 1994 Vascular malformations of the brain in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease). Surg Neurol 41:374-380
8. Allen SW, Whitfield JM, Clarke DR, Sujansky E, Wiggins JW 1993 Pulmonary arteriovenous malformations in the newborn: a familial case. Pediatr Cardiol 14:58-61
9. Ribet M, Denibal F 1991 Malformations artério-veineuses pulmonaires. Chirurgie 117:533-541
10. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, McCormick MK, Pericak-Vance MA, Heutink P, Oostra BA, Haitjema T, Westerman CJJ, Porteus ME, Guttmacher AE, Letarte M, Marchuk DA 1994 Endoglin, a TGF-β binding protein of endothelial cells is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345-351
11. Vincent P, Plauchu H, Hazan J, Fauré S, Weissenbach J, Godet J 1995 A third locus for hereditary haemorrhagic telangectasia maps to chromosome 12q. Hum Mol Genet 4:945-949
12. Johnson DW, Berg JN, Gallione CJ, McAllister KA, Warner JP, Helmbold EA, Markel DS, Jackson CE, Porteus MEM, Marchuk DA 1995 A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. Genet Res 5:21-28
13. Berg JN, Gallione CJ, Stenzel TT, Johnson DW, Allen WP, Schwartz CE, Jackson CE, Porteous MEM, Marchuk DA 1997 The activin receptor-like kinase 1 gene: genetic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 6:60-67
14. Heutink P, Haitjema T, Breedveld GJ, Janssen B, Sandkuijl LA, Bontekoe CJM, Westerman CJJ, Oostra BA 1994 Linkage of hereditary haemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity. J Med Genet 31:933-936
15. McAllister KA, Lennon F, Bowles-Biesecker B, McKinnon WC, Helmbold EA, Markel DS, Jackson CE, Guttmacher AE, Pericak-Vance MA, Marchuk DA 1994 Genetic heterogeneity in hereditary haemorrhagic telangiectasia: possible correlation with clinical phenotype. J Med Genet 31:927-932
16. Porteous MEM, Curtis A, Williams O, Marchuk D, Bhattacharya SS, Burn J 1994 Genetic heterogeneity in hereditary haemorrhagic telangiectasia. J Med Genet 31:925-926
17. Berg JN, Guttmacher AE, Marchuk DA, Porteous MEM 1996 Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 33:256-257
18. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Porteus MEM, Marchuk DA 1996 Mutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2. Nature Genet 13:189-195
19. Gougos A, Letarte M 1988 Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol 141:1925-1933
20. Letarte M, Greaves A, Vera S 1995 CD105 (endoglin) cluster report. In: Schlossman SF, Boumsell L, Gilks W, Harlan J, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder T, Todd R (eds) Leukocyte Typing V. White Cell Differentiation Antigens. Oxford University Press. Oxford, pp 1756-1759
21. Gougos A, St. Jacques S, Greaves A, O'Connell PJ, d'Apice AJF, Buhring HJ, Bernabeu C, van Mourik JA, Letarte M 1992 Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 4:83-92
22. St-Jacques S, Forte M, Lye SJ, Letarte M 1994 Localization of endoglin, a transforming growth factor-β binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod 51:405-413
23. Attisano L, Carcamo J, Ventura F, Weis FMB, Massagué J, Wrana JL 1993 Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75:671-680
24. Pachenko MP, Williams MC, Brody JS, Qiang Y 1996 Type I receptor serine-threonine kinase preferentially expressed in pulmonary blood vessels. Am J Physiol 270:L547-L558
25. Cheifetz S, Bellon T, Calés C, Vera S, Bernabeu C, Massagué J, Letarte M 1992 Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J Biol Chem 267:19027-19030
26. Lastres P, Letamendia A, Zhang H, Rius C, Almendro N, Lopez LA, Langa C, Fabra A, Letarte M, Bernabeu C 1996 Endoglin modulates cellular responses to TGF-β1. J Cell Biol 133:1109-1121
27. Caniggia I, Taylor CV, Ritchie JWK, Lye SJ, Letarte M 1997 Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology 138:4977-4988
28. Pece Barbara N, Wrana J, Letarte M 1999 Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily. J Biol Chem 274:584-594
29. Letamendia A, Lastres P, Botella LM, Raab U, Langa C, Velasco B, Attisano L, Bernabeu C 1998 Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan. J Biol Chem 273:33011-33019
30. ten Dijke P, Yamashita H, Ichijo H, Franzen P, Laiho M, Miyazono K, Heldin CH 1994 Characterization of the type I receptors for transforming growth factor β receptor-like and activin. Science 264:101-104
31. Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL 1998 Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J Biol Chem 273:25628-25636
32. Lastres P, Bellon T, Cabanas C, Sanchez-Madrid F, Acevedo A, Gougos A, Letarte M, Bernabeu C 1992 Regulated expression on human macrophages of endoglin, an RGD containing surface antigen. Eur J Immunol 22:393-397
33. Pece N, Vera S, Cymerman U, White RIJ, Wrana JL, Letarte M 1997 Mutant endoglin in hereditary hemorrhagic telangiectasia type I is transiently expressed intracellularly and is not a dominant negative. J Clin Invest 100:2568-2579
34. Pece N, Cymerman U, Vera S, Marchuk D, Letarte M 1999 Expression analysis of four endoglin missense mutations suggests haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type I. Hum Mol Genet 8:2171-2181
35. McAllister KA, Baldwin MA, Thukkani AK, Gallione CJ, Berg JN, Porteus ME, Guttmacher AE, Marchuk DA 1995 Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet 4:1983-1985
36. Shovlin CL, Hughes JMB, Scott J, Seidman CE, Seidman JG 1997 Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 61:68-79
37. Yamaguchi H, Azuma H, Shigekiyo T, Inoue H 1997 A novel missense mutation in the endoglin gene in hereditary hemorrhagic telangiectasia. Thromb Haemost 77:243-247
38. Gallione CJ, Klaus DJ, Yeh EY, Stenzel TT, Xue Y, Anthony KB, McAllister KA, Baldwin MA, Berg JN, Lux A, Smith JD, Vary CPH, Craighen WJ, Westermann CJJ, Warner ML, Miller YE, Jackson CE, Guttmacher AE, Marchuk DA 1998 Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles. Hum Mutat 11:286-294
39. Shovlin C, Letarte M 1999 Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 54:714-729
40. Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, King SW, Letarte M, Vitetta ES, Thorpe PE 1995 Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1:1623-1634
41. Pichuantes S, Vera S, Bourdeau A, Pece N, Kumar S, Wayner EA, Letarte M 1997 Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments. Tissue Antigens 50:265-276
42. Rius C, Smith JD, Almendro N, Langa C, Botella LM, Marchuk DA, Vary CPH, Bernabeu C 1998 Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1. Blood 92:4677-4690
43. Graulich W, Nettlebeck DM, Fischer D, Kissel T, Muller R 1999 Cell type specificity of the human endoglin promoter. Gene 227:55-62
44. Bourdeau A, Cymerman U, Paquet M-E, Meschino W, McKinnon WC, Guttmacher AE, Becker L, Le Tarte M 2000 Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with Hereditary Hemorrhagic Telangiectasia Type 1. Am J Pathol 156: in press.
45. Ioannou P, Christopoulos G, Panayides K, Kleanthous M, Middleton L 1992 Detection of Duchenne and Becker muscular dystrophy carriers by quantitative multiplex polymerase chain reaction analysis. Neurology 42:1783-1790
46. Fullbright RK, Chaloupka JC, Putman CM, Sze GK, Merriam MM, Lee GK, Fayad PB, Awad IA, White RIJ 1998 MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR 19:477-484